These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5068187)
21. Kanamycin serum half-life and renal function: age and sex. Nielsen B; Sorensen AW; Szabo L; Pedersen EA; Scharff A Dan Med Bull; 1973 Oct; 20(5):144-9. PubMed ID: 4770767 [No Abstract] [Full Text] [Related]
22. A nomogram for drug dosage in renal failure, based on mean plasma concentrations. Ash SR; Jacobi J Int J Artif Organs; 1983 May; 6(3):101-4. PubMed ID: 6874119 [No Abstract] [Full Text] [Related]
23. An outlook on pharmacokinetics in chemotherapy. Otaya H Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):430-2. PubMed ID: 700916 [No Abstract] [Full Text] [Related]
24. [Dosage of drugs with regard to their distribution volume and biological half-life]. Dahl SG Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1201-2. PubMed ID: 4839999 [No Abstract] [Full Text] [Related]
25. Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs. Frazier DL; Aucoin DP; Riviere JE J Am Vet Med Assoc; 1988 Jan; 192(1):57-63. PubMed ID: 3343180 [TBL] [Abstract][Full Text] [Related]
26. Intravenous administration of kanamycin and gentamicin in newborn infants. McCracken GH; Threlkeld N; Thomas ML Pediatrics; 1977 Oct; 60(4):463-6. PubMed ID: 905011 [TBL] [Abstract][Full Text] [Related]
27. Drug dosage in patients with impaired renal function. Dettli L; Spring P; Habersang R Postgrad Med J; 1970 Oct; ():Suppl:32-5. PubMed ID: 5488205 [No Abstract] [Full Text] [Related]
30. Nephro-pharmacology. Keller F; Ludwig U; Czock D Int J Clin Pharmacol Ther; 2006 Aug; 44(8):343. PubMed ID: 16961164 [No Abstract] [Full Text] [Related]
31. [Reversible drug-induced uremia in chronic kidney diseases]. Minetti L; De Min A; Grossi C; Torelli D Minerva Nefrol; 1976; 23(1):19-24. PubMed ID: 995327 [No Abstract] [Full Text] [Related]
32. [Spacing doses of amikacin in renal failure patients. Calculation based on blood creatinine expressed in micromoles]. Granthil C; Alazia M; Dubouloz F Presse Med; 1983 May; 12(20):1300-1. PubMed ID: 6222307 [No Abstract] [Full Text] [Related]
33. A set of simple aids to drug dosage adjustment in renal insufficiency. Janků I; Modr Z; Krebs V Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):27-32. PubMed ID: 2303310 [TBL] [Abstract][Full Text] [Related]
34. [Postoperative gentamycin therapy. Serum levels depending on dosage and temporary kidney dysfunction]. Straube W; Tiesler E; Federspil P Med Klin; 1972 Jul; 67(27):941-5. PubMed ID: 5048691 [No Abstract] [Full Text] [Related]
35. Computerized drug dosing in renal failure: a real problem and a practical solution. Greenburg AG; Adachi W; McClure DK; Lawhead RA; Peskin GW J Trauma; 1978 May; 18(5):308-16. PubMed ID: 660683 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and clearances related to renal processes. Garrett ER Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):155-72. PubMed ID: 649235 [No Abstract] [Full Text] [Related]
37. Practical pharmacokinetic techniques for drug consultation and evaluation. II. A perspective on the renal impaired patient. Schumacher GE Am J Hosp Pharm; 1973 Sep; 30(9):824-30. PubMed ID: 4582138 [No Abstract] [Full Text] [Related]
38. The development of a drug dosage adjustment service for patients with renal impairment. Libiszewski D J Clin Hosp Pharm; 1981 Mar; 6(1):39-49. PubMed ID: 7345095 [TBL] [Abstract][Full Text] [Related]
39. Modeling and predicting drug pharmacokinetics in patients with renal impairment. Rowland Yeo K; Aarabi M; Jamei M; Rostami-Hodjegan A Expert Rev Clin Pharmacol; 2011 Mar; 4(2):261-74. PubMed ID: 22115405 [TBL] [Abstract][Full Text] [Related]